ReadYourDNA

Rosuvastatin (Crestor)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Rosuvastatin

What it is

Rosuvastatin is a statin: it blocks HMG-CoA reductase, the liver enzyme that makes cholesterol, so the liver takes more LDL cholesterol out of the blood. It is one of the strongest statins and is used to lower cholesterol and to reduce the chance of heart attack and stroke. It is sold as Crestor, among other names.

How genes come into it

Rosuvastatin is barely broken down by liver enzymes; what decides its blood level is mainly transport. SLCO1B1 carries it into the liver, and ABCG2 pumps it out of gut and liver cells. Common weaker versions of either (rs4149056 in SLCO1B1, rs2231142 in ABCG2, the latter most frequent in East Asian populations) raise blood levels. CPIC has published a guideline on both genes and rosuvastatin, DPWG on SLCO1B1, and the US FDA lists an effect on drug levels. Other genes linked to how much cholesterol falls have been studied, with weaker evidence.

Published guidelines

Clinical guidelines that name a gene for Rosuvastatin. They sort people into groups by the gene copies they carry.

CPIC guideline: ABCG2, SLCO1B1. ABCG2: Normal Function, Poor Function, Decreased Function, No Result · SLCO1B1: Normal Function, Poor Function, Increased Function, Decreased Function, Possible Decreased Function, Indeterminate, No Result. Strong. 2022.

DPWG guideline: SLCO1B1. Normal Function · Poor Function · Increased Function · Decreased Function · Possible Decreased Function · Indeterminate. 2024.

US FDA: SLCO1B1. Poor Function. Data that Demonstrate a Potential Impact on Pharmacokinetic Properties Only.

What research found

Every published finding on gene variants and Rosuvastatin. Upload your DNA file to see which of these rows apply to you.

Rated evidence (24 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

SLCO1B1 SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37: Level 1A · replicated. Metabolism/PK. 14.

SLCO1B1 rs4149056: Level 1A · replicated. Metabolism/PK: Hypercholesterolemia. 13.

ABCG2 rs2231142: Level 1A · replicated. Metabolism/PK. 11.

SLCO1B1 rs4149056: Level 1A · replicated. Toxicity: statin-related myopathy. 8.

Metabolism (47 findings)

Studies of how quickly the body processes this medication.

ABCB11 rs2287622: Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.

ABCB11 rs7579275: Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.

ABCC2 rs17216177: Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.

ABCC2 rs17216198: Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.

Response (33 findings)

Studies of how well it worked in people carrying a variant.

ABCA1 rs2230806: Allele T is associated with decreased response to atorvastatin, rosuvastatin or simvastatin as compared to allele C.

ABCA1 rs769705621: Allele AAAA is associated with decreased response to atorvastatin, rosuvastatin or simvastatin in people with familial hypercholesterolemia as compared to genotypes A/AA + A/del.

ABCG2 rs1481012: Genotypes AG + GG are associated with increased response to rosuvastatin as compared to genotype AA.

ABCG2 rs2199936: Genotypes AA + AG are associated with increased response to rosuvastatin as compared to genotype GG.

Dosing (1 finding)

Studies of how much of the drug people needed or tolerated.

SLCO2B1 rs2306168: Genotype TT is not associated with concentrations of glibenclamide, rosuvastatin or sulfasalazine in healthy individuals as compared to genotype CC.

Other findings (1 finding)

Studies that do not fall into the groups above.

APOA5 rs662799: Genotype AA is associated with response to atorvastatin, rosuvastatin and simvastatin in people with Dyslipidaemia as compared to genotypes AG + GG.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Baycol (Statins)

Lescol (Statins)

Lipitor (Statins)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com